We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00316420
Recruitment Status : Completed
First Posted : April 20, 2006
Last Update Posted : March 8, 2010
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
Swedish Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2009
  Study Completion Date : August 2009